Participated · Seed · Aug 2026

Perkant Tech was founded in June 2020 and develops Abhay Parimiti, a seven-inch-screen portable device the company describes as an AI-integrated system that analyses over 700 body signals to produce an automated health assessment in under 60 seconds. The company lists the device price at Rs 20,000 and says it manufactures from facilities in Madhya Pradesh and Andhra Pradesh. Perkant claims the system provides instant indicators across cardiac and respiratory health and for measures such as pre-diabetes, glucose, haemoglobin and bilirubin, and markets the platform as a ‘digital doctor’ and a multi-disease prognosis range. The firm holds a granted Indian patent and has filed a U.S. patent application; however, the articles note no peer-reviewed clinical validation and no public evidence of clearance from India’s medical device regulator. Perkant reported successful pilots and a planned commercial launch, but the articles state there are no publicly reported customers, deployments or revenue. The company participated in the Qualcomm Women Entrepreneurs India Network cohort and showcased the device at Nokia’s 6G laboratory event, with six employees listed in mid-2024.

Participated · Equity · May 2024

BharatRohan offers a Drone-based Decision Support System (DSS) called BharatRohan® CropAssure® that delivers hyperspectral and multispectral remote sensing to identify diseases, pests, and nutritional deficiencies at early stages. The platform provides real-time, data-driven insights to enable Integrated Pest Management (IPM) strategies and optimized resource allocation for farmers. It currently supports 50,000 farmers across 200,000 acres in five Indian states. The company plans to develop proprietary edge-computing drones for precise crop monitoring and variable pesticide application, and to design compact hyperspectral and multispectral sensors for drones. BharatRohan intends to distribute these drones via franchise-based models to rural entrepreneurs who will offer CropAssure® services. The firm has also begun procuring residue-free farm produce from farmers using its IPM services and aims to introduce that produce to global consumers while expanding operations to 15 states and 1,000,000 acres by 2025.

Led · Seed · Aug 2022

Yostra Labs develops point-of-care diagnostic and wound-care devices aimed at managing major chronic diseases, notably diabetic foot complications. Its flagship products are NEURO TOUCH, a screening device for peripheral neuropathy, and VELOX Care, an advanced wound care solution for chronic wounds including diabetic foot ulcers. The company says it has screened over 40,000 patients across clinics, hospitals, and diagnostic centers in India. Yostra was founded in 2014 and is using its seed financing to commercialize its product portfolio and scale production. With the new funds it plans to hire additional sales and marketing talent, optimize its bill of materials, and expand market reach. The startup positions its technology as addressing a widely neglected complication of diabetes that the article states carries mortality higher than many cancers.